4//SEC Filing
Costello Beth Ann 4
Accession 0001225208-26-000337
CIK 0000874766other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:11 PM ET
Size
22.2 KB
Accession
0001225208-26-000337
Insider Transaction Report
Form 4
Costello Beth Ann
EVP and CFO
Transactions
- Exercise/Conversion
Common Stock
2026-01-02$48.89/sh+35,339$1,727,724→ 112,912.606 total - Sale
Common Stock
2026-01-02$137.04/sh−11,368$1,557,837→ 101,544.606 total - Sale
Common Stock
2026-01-02$136.37/sh−23,971$3,268,935→ 77,573.606 total - Exercise/Conversion
Stock Option
2026-01-02−35,339→ 0 totalExercise: $48.89Exp: 2027-02-28→ Common Stock (35,339 underlying)
Holdings
- 75,790
Stock Option
Exercise: $49.01Exp: 2029-02-26→ Common Stock (75,790 underlying) - 67,204
Stock Option
Exercise: $51.87Exp: 2031-02-23→ Common Stock (67,204 underlying) - 63,194
Stock Option
Exercise: $53.81Exp: 2028-02-27→ Common Stock (63,194 underlying) - 71,318
Stock Option
Exercise: $55.27Exp: 2030-02-25→ Common Stock (71,318 underlying) - 75,483
Stock Option
Exercise: $69.41Exp: 2032-02-23→ Common Stock (75,483 underlying) - 57,492
Stock Option
Exercise: $78.28Exp: 2033-02-28→ Common Stock (57,492 underlying) - 25,223
Stock Option
Exercise: $95.74Exp: 2034-02-27→ Common Stock (25,223 underlying) - 21,847
Stock Option
Exercise: $116.41Exp: 2035-02-25→ Common Stock (21,847 underlying)
Footnotes (12)
- [F1]The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Ms. Costello on August 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F10]One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
- [F11]One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
- [F12]One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
- [F2]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $136.90 - $137.19 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $135.90 - $136.90 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.
- [F5]The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
- [F6]The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
- [F7]The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
- [F8]The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
- [F9]The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
Documents
Issuer
HARTFORD INSURANCE GROUP, INC.
CIK 0000874766
Entity typeother
Related Parties
1- filerCIK 0001399852
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:11 PM ET
- Size
- 22.2 KB